Artem Kondratskyi

Artem Kondratskyi

Auto-generated profile, based on publicly available information

Artem Kondratskyi

Nanion Technologies GmbH, Munich, Germany

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
KKKateryna Kondratska
Kateryna Kondratska
AKArtem Kondratskyi
Artem Kondratskyi
MYMaya Yassine
Maya Yassine
Loic LemonnierLoic Lemonnier
Loic Lemonnier
GLGilbert Lepage
Gilbert Lepage
Natalia PrevarskayaNatalia Prevarskaya
Natalia Prevarskaya

1 January 2013 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
AKArtem Kondratskyi
Artem Kondratskyi
MYMaya Yassine
Maya Yassine
KKKateryna Kondratska
Kateryna Kondratska
RSRoman Skryma
Roman Skryma
CSChristian Slomianny
Christian Slomianny
Natalia PrevarskayaNatalia Prevarskaya
Natalia Prevarskaya
Autophagy, or cellular self-eating, is a tightly regulated cellular pathway the main purpose of which is lysosomal degradation and subsequent recycling of cytoplasmic material to maintain normal cellular homeostasis. Defects in autophagy are linked to a variety of pathological states, including cancer. Cancer is the disease associated with abnormal tissue growth following an alteration in such fundamental cellular processes as apoptosis, proliferation, differentiation, migration and autophagy. The role of autophagy in cancer is complex, as it can promote both tumor prevention and survival/treatment resistance. It's now clear that modulation of autophagy has a great potential in cancer diagnosis and treatment. Recent findings identified intracellular calcium as an important regulator of both basal and induced autophagy. Calcium is a ubiquitous secondary messenger which regulates plethora of physiological and pathological processes such as aging, neurodegeneration and cancer. The role of calcium and calcium-permeable channels in cancer is well-established, whereas the information about molecular nature of channels regulating autophagy and the mechanisms of this regulation is still limited. Here we review existing mechanisms of autophagy regulation by calcium and calcium-permeable ion channels. Furthermore, we will also discuss some calcium-permeable channels as the potential new candidates for autophagy regulation. Finally we will propose the possible link between calcium permeable channels, autophagy and cancer progression and therapeutic response.

23 November 2017 in Autophagy
Verified
Journal Article
Closed access
AKArtem Kondratskyi
Artem Kondratskyi
KKKateryna Kondratska
Kateryna Kondratska
RSRoman Skryma
Roman Skryma
DKDaniel J. Klionsky
Daniel J. Klionsky
Natalia PrevarskayaNatalia Prevarskaya
Natalia Prevarskaya
Autophagy is a cellular process in which the cell degrades and recycles its own constituents. Given the crucial role of autophagy in physiology, deregulation of autophagic machinery is associated with various diseases. Hence, a thorough understanding of autophagy regulatory mechanisms is crucially important for the elaboration of efficient treatments for different diseases. Recently, ion channels, mediating ion fluxes across cellular membranes, have emerged as important regulators of both basal and induced autophagy. However, the mechanisms by which specific ion channels regulate autophagy are still poorly understood, thus underscoring the need for further research in this field. Here we discuss the involvement of major types of ion channels in autophagy regulation.

2 March 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
ABAlexis Bavencoffe
Alexis Bavencoffe
Dimitra GkikaDimitra Gkika
Dimitra Gkika
AKArtem Kondratskyi
Artem Kondratskyi
BBBenjamin Beck
Benjamin Beck
ABAnne-Sophie Borowiec
Anne-Sophie Borowiec
Natalia PrevarskayaNatalia Prevarskaya
Natalia Prevarskaya
The transient receptor potential channel melastatin member 8 (TRPM8) is expressed in sensory neurons, where it constitutes the main receptor of environmental innocuous cold (10-25 degrees C). Among several types of G protein-coupled receptors expressed in sensory neurons, G(i)-coupled alpha 2A-adrenoreceptor (alpha 2A-AR), is known to be involved in thermoregulation; however, the underlying molecular mechanisms remain poorly understood. Here we demonstrated that stimulation of alpha 2A-AR inhibited TRPM8 in sensory neurons from rat dorsal root ganglia (DRG). In addition, using specific pharmacological and molecular tools combined with patch-clamp current recordings, we found that in heterologously expressed HEK-293 (human embryonic kidney) cells, TRPM8 channel is inhibited by the G(i) protein/adenylate cyclase (AC)/cAMP/protein kinase A (PKA) signaling cascade. We further identified the TRPM8 S9 and T17 as two key PKA phosphorylation sites regulating TRPM8 channel activity. We therefore propose that inhibition of TRPM8 through the alpha 2A-AR signaling cascade could constitute a new mechanism of modulation of thermosensation in both physiological and pathological conditions.

20 August 2008 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JBJoel P Baumgart
Joel P Baumgart
IVIuliia Vitko
Iuliia Vitko
IBIsabelle Bidaud
Isabelle Bidaud
AKArtem Kondratskyi
Artem Kondratskyi
PLPhilippe Lory
Philippe Lory
EPEdward Perez-Reyes
Edward Perez-Reyes
The intracellular loops that interlink the four transmembrane domains of Ca2+- and Na+-channels (Cav, Nav) have critical roles in numerous forms of channel regulation. In particular, the intracellular loop that joins repeats I and II (I–II loop) in high voltage-activated (HVA) Ca2+ channels possesses the binding site for Cavβ subunits and plays significant roles in channel function, including trafficking the α1 subunits of HVA channels to the plasma membrane and channel gating. Although there is considerable divergence in the primary sequence of the I–II loop of Cav1/Cav2 HVA channels and Cav3 LVA/T-type channels, evidence for a regulatory role of the I–II loop in T-channel function has recently emerged for Cav3.2 channels. In order to provide a comprehensive view of the role this intracellular region may play in the gating and surface expression in Cav3 channels, we have performed a structure-function analysis of the I–II loop in Cav3.1 and Cav3.3 channels using selective deletion mutants. Here we show the first 60 amino acids of the loop (post IS6) are involved in Cav3.1 and Cav3.3 channel gating and kinetics, which establishes a conserved property of this locus for all Cav3 channels. In contrast to findings in Cav3.2, deletion of the central region of the I–II loop in Cav3.1 and Cav3.3 yielded a modest increase (+30%) and a reduction (−30%) in current density and surface expression, respectively. These experiments enrich our understanding of the structural determinants involved in Cav3 function by highlighting the unique role played by the intracellular I–II loop in Cav3.2 channel trafficking, and illustrating the prominent role of the gating brake in setting the slow and distinctive slow activation kinetics of Cav3.3.

1 August 2013 in Cell Reports
Verified
Journal Article
Open access
GSGeorge Shapovalov
George Shapovalov
Dimitra GkikaDimitra Gkika
Dimitra Gkika
MDMaily Devilliers
Maily Devilliers
AKArtem Kondratskyi
Artem Kondratskyi
DGDmitri Gordienko
Dmitri Gordienko
Natalia PrevarskayaNatalia Prevarskaya
Natalia Prevarskaya
Stimulation of μ-opioid receptors (OPRMs) brings powerful pain relief, but it also leads to the development of tolerance and addiction. Ensuing withdrawal in abstinent patients manifests itself with severe symptoms, including cold hyperalgesia, often preventing addicted patients from successfully completing the rehabilitation. Unsurprisingly, OPRMs have been a central point of many studies. Nonetheless, a satisfactory understanding of the pathways leading to distorted sensory responses during opiate administration and abstinence is far from complete. Here, we present a mechanism that leads to modulation by OPRMs of one of the sensory responses, thermosensation. Activation of OPRM1 leads to internalization of a cold-sensor TRPM8, which can be reversed by a follow-up treatment with the inverse OPRM agonist naloxone. Knockout of TRPM8 protein leads to a decrease in morphine-induced cold analgesia. The proposed pathway represents a universal mechanism that is probably shared by regulatory pathways modulating general pain sensation in response to opioid treatment.